Table 1.
Emerging studies on patients with severe COVID-19 and the rates of diabetes, hypertension, and cerebrovascular disease
| Study | Diabetes (%) | Hypertension (%) | Cerebrovascular disease (%) |
|---|---|---|---|
| Yang et al. 202010 32 nonsurvivors from a cohort of 52 intensive-care patients |
22 | Not stated | 22 |
| Guan et al. 202011 173 patients with severe disease from a study of 1099 patients |
16.2 | 23.7 | 2.3 |
| Zhang et al. 202012 140 hospitalized patients |
12 | 30 | Not stated |
| Deng et al. 202013 26 fatal cases |
42 | 54 | 15 |
| Wu et al. 202014 201 patients who developed acute respiratory distress syndrome or died |
19.0 | 27.4 | Not stated |
Abbreviation used: COVID-19, coronavirus 2019.